Pleural Mesothelioma Clinical Trials

46 clinical trials for Pleural Mesothelioma across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — RECRUITING · PHASE1
• TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO — RECRUITING
• Evaluation of Skin Tests in Biotherapy Allergies — RECRUITING · NA
• A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy — RECRUITING · PHASE1
• INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) — RECRUITING · NA
• TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study — RECRUITING
• A Beta-only IL-2 ImmunoTherapY Study — RECRUITING · PHASE1
• The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma — RECRUITING · PHASE2
• A Study of MT027 in Patients with Pleural Malignant Tumors — RECRUITING · PHASE1
• A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER, GLOBAL STUDY OF VOLRUSTOMIG (MEDI5752) IN COMBINATION WITH CARBOPLATIN PLUS PEMETREXED VERSUS PLATINUM PLUS PEMETREXED OR NIVOLUMAB PLUS IPILIMUMAB IN PARTICIPANTS WITH UNRESECTABLE PLEURAL MESOTHELIOMA (EVOLVE-MESO) — RECRUITING · PHASE3
• A PHASE II RANDOMIZED STUDY OF PEMBROLIZUMAB IN PATIENTS WITH ADVANCED MALIGNANT PLEURAL MESOTHELIOMA — RECRUITING · PHASE2
• Mesothelioma Early Detection by VOCs — TERMINATED
• NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours — TERMINATED · PHASE1
• Giving Upfront Anti-p40 to Reduce toxicity from Dual Immune Checkpoint Inhibition in MESOthelioma — NOT_YET_RECRUITING · PHASE2
• IFCT-2403 BI-MAPS Assessment of ivonescimab as salvage treatment in relapsing pleural mesothelioma patients, previously treated by immunotherapy and standard chemotherapy — TERMINATED · PHASE2
• A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers — SUSPENDED · PHASE2
• FAPI PET in Pleural Mesothelioma: The Diagnostic Accuracy and Clinical Value of FAPI PET at Diagnosis, Primary Staging, and the Feasibility of FAPI PET for Response Evaluation — TERMINATED · PHASE2
• From Presentation to Diagnosis: Patterns of Pleural Effusion — COMPLETED
• DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma — COMPLETED · PHASE3
• Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) — ACTIVE_NOT_RECRUITING · PHASE2
• IFCT-2402 LAG-MAPS A non-comparative phase IIR trial assessing fianlimab plus cemiplimab plus pemetrexed-platinum chemotherapy or cemiplimab plus pemetrexed-platinum chemotherapy for treatment-naive Pleural Mesothelioma (PM) patients — TERMINATED · PHASE2
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) — TERMINATED · PHASE2
• Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma — COMPLETED · PHASE1
• A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malignant Pleural Mesothelioma — TERMINATED · PHASE1
• Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma — NOT_YET_RECRUITING · PHASE2
• Evaluation of Response by FLT PET in Mesothelioma — OTHER · NA
• eRAPID: Online Symptom Reporting in Lung Cancer — COMPLETED · NA
• Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma — OTHER · PHASE2
• Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma — OTHER
• Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma — COMPLETED · PHASE2
• Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention — OTHER
• A Study of SGN-CD228A in Advanced Solid Tumors — TERMINATED · PHASE1
• Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S — COMPLETED · PHASE1
• TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients — COMPLETED · PHASE1
• A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia — OTHER · PHASE4
• Trimodal Lung-Sparing Treatment of Pleural Mesothelioma — TERMINATED · PHASE2
• Gene Therapy for Pleural Malignancies — COMPLETED · PHASE1
• International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) — OTHER
• Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program — COMPLETED · NA
• PHASE 1 SAFETY RUN-IN AND PHASE 2 RANDOMIZED CLINICAL TRIAL OF ANETUMAB RAVTANSINE AND MK-3475 (PEMRBOLIZUMAB) COMPARED TO MK-3475 (PEMBROLIZUMAB) ALONE FOR MESOTHELIN-POSITIVE MALIGNANT PLEURAL MESOTHELIOMA — COMPLETED · PHASE2
• Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy — COMPLETED · PHASE2
• Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma — TERMINATED · PHASE2
• Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate — TERMINATED · PHASE2
• A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1) — OTHER · PHASE2
• Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate — COMPLETED · PHASE2
• Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma — COMPLETED · PHASE1

Refine this search